---
figid: PMC9354605__fimmu-13-887471-g003
figtitle: 'Landscape of chimeric antigen receptor T cell therapy in breast cancer:
  Perspectives and outlook'
organisms:
- Adenoviridae
- Foot-and-mouth disease virus
- Homo sapiens
- Mus musculus
organisms_ner:
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
pmcid: PMC9354605
filename: fimmu-13-887471-g003.jpg
figlink: /pmc/articles/PMC9354605/figure/f3/
number: F3
caption: Fundamental structure diagram of a CAR-T cell and the development flowchart
  from the first-generation to the new-generation CAR-T cell. The fundamental structure
  of CAR-T cells is composed of extracellular tumor antigen-binding domains, hinge
  domains, transmembrane domains, and intracellular signaling domains. The first generation
  of CAR-T cells contained only a CD3ζ intracellular signaling domain. The second
  or third generation of CAR-T cells added one or more costimulatory molecules based
  on the previous generation. The next generation of CAR-T cells applied a variety
  of new engineering strategies, including bispecific CARs, the switch, nanobodies,
  caspase 9, and the cytokine pathway.
papertitle: 'The landscape of chimeric antigen receptor T cell therapy in breast cancer:
  Perspectives and outlook.'
reftext: Hao Zhang, et al. Front Immunol. 2022;13:887471.
year: '2022'
doi: 10.3389/fimmu.2022.887471
journal_title: Frontiers in Immunology
journal_nlm_ta: Front Immunol
publisher_name: Frontiers Media S.A.
keywords: chimeric antigen receptor | CAR-T cell | immunotherapy | breast cancer |
  tumor microenvironment
automl_pathway: 0.93746
figid_alias: PMC9354605__F3
figtype: Figure
redirect_from: /figures/PMC9354605__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9354605__fimmu-13-887471-g003.html
  '@type': Dataset
  description: Fundamental structure diagram of a CAR-T cell and the development flowchart
    from the first-generation to the new-generation CAR-T cell. The fundamental structure
    of CAR-T cells is composed of extracellular tumor antigen-binding domains, hinge
    domains, transmembrane domains, and intracellular signaling domains. The first
    generation of CAR-T cells contained only a CD3ζ intracellular signaling domain.
    The second or third generation of CAR-T cells added one or more costimulatory
    molecules based on the previous generation. The next generation of CAR-T cells
    applied a variety of new engineering strategies, including bispecific CARs, the
    switch, nanobodies, caspase 9, and the cytokine pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SCFV
  - CR1
  - TNFRSF9
  - ICOS
  - TNFRSF4
  - CD27
  - BCL2L10
  - CXCL10
  - CXCL11
  - CXCL12
  - CXCL13
  - CXCL14
  - CXCL9
  - PF4
  - CXCL1
  - CXCL2
  - CXCL3
  - CXCL5
  - CXCL6
  - CXCL8
  - PPBP
  - CD28
  - CARS1
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - Cr2
  - Tnfrsf9
  - Icos
  - Tnfrsf4
  - Cd27
  - Bcl2l10
  - Cd28
  - Cars1
  - Casp9
  - oo
  - Pa
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - CysRS
  - Dronc
---
